MEDTR vs KLSYN Comparison
Price, market cap, valuation, profitability and leverage metrics of MEDTR and KLSYN side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | MEDTR | KLSYN | Sector median |
|---|---|---|---|
| Last price (TL) | 18.62 | 14.23 | 18.72 |
| Daily change | −4.02% | −3.20% | −4.65% |
| Market cap | TRY 2.2B | TRY 6.1B | TRY 4.4B |
| P/E | 66.43 | 190.08 | 18.20 |
| P/B | 0.69 | 1.59 | 1.14 |
| Dividend yield | 0.44% | 0.93% | 0.90% |
| Return on equity | 1.14% | 0.92% | 1.78% |
| Free float | 20.21% | 23.92% | 37.21% |
Popular comparisons
Related pages
About the MEDTR vs KLSYN comparison
Price, market cap, valuation multiples, profitability and leverage of MEDTR (Meditera Tibbi Malzeme) and KLSYN (Koleksiyon Mobilya) side by side as of Sep 28, 2026, 11:54. Of the 15 metrics compared, MEDTR leads in 9 and KLSYN leads in 6.
Highlights: Daily change: KLSYN leads (−3.20% vs −4.02%). Market cap: KLSYN leads (TRY 6.1B vs TRY 2.2B). P/E: MEDTR leads (66.43 vs 190.08). P/B: MEDTR leads (0.69 vs 1.59). EV/EBITDA: MEDTR leads (7.60 vs 24.74). EV/Sales: MEDTR leads (1.36 vs 6.69). Dividend yield: KLSYN leads (0.93% vs 0.44%). Gross margin: KLSYN leads (44.66% vs 33.71%).
Frequently asked questions
Is MEDTR or KLSYN cheaper?
By P/E, MEDTR is cheaper (66.43 vs 190.08); by P/B, MEDTR trades at the lower multiple (0.69 vs 1.59).
Which is more profitable, MEDTR or KLSYN?
Annual net margin is 1.35% for MEDTR and 1.82% for KLSYN; return on equity is 1.14% for MEDTR and 0.92% for KLSYN.
Which is more leveraged, MEDTR or KLSYN?
The leverage ratio is 15.79 for MEDTR and 37.89 for KLSYN; net debt/EBITDA is — for MEDTR and 1.34 for KLSYN. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.